Zippy follows Ava, a teenage patient with diabetes, through the halls of Children’s Hospital Los Angeles, hoping to engage her in a conversation about clinical trials. Ava, a teenager with diabetes, and Zippy the research robot “Keep your research studies to yourself!” Ava say…
Lecturers examined the FDA's regulatory requirements for the monitoring, detection, assessment, and safety reporting of adverse effects of drugs, devices, and other medical products.
A seminar co-sponsored by the SC CTSI and Keck School of Medicine showed researchers how to think like a reviewer and write better proposals.
The unexpected findings suggest that people with bad cases of the common skin condition are 36 percent more likely to attempt suicide, suggesting heightened focus by dermatology providers on related psychiatric concerns.
New analysis reveals faster, more efficient trial activation
SC CTSI to lead first “synergy paper” collaboration on local health partnerships in Los Angeles and Chicago
Get support to apply to the NIH Helping to End Addiction Long-term (HEAL) Initiative to address the opioid crisis.
Two Department of Dermatology investigators have shown that a commonly-used antibiotic can trigger production of a collagen protein type necessary for normal skin.
NIH Funding Acknowledgment: Important - All publications resulting from the utilization of SC CTSI resources are required to credit the SC CTSI grant by including the NIH funding acknowledgment and must comply with the NIH Public Access Policy.